Microtest Diagnostics provides automated multiplex in vitro diagnostic tests for allergies, influenza, autoimmune, and infectious Disease.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: London
State: England
Zip:
Country: United Kingdom
Microtest Diagnostics was spun out of London’s Imperial College in 2002 with a mission to provide automated multiplex in-vitro diagnostic tests in the areas of Allergy, Autoimmune, Influenza and Infectious Disease. Following more than 10 years of development and over USD $10 million in R&a;D investment, Microtest Diagnostics recently CE-marked the ADAM™ instrument. The company operates with a highly skilled team of trained professionals with expertise across numerous fields including product, software and hardware design, instrument and assay development, regulatory approvals and quality control. Our facilities are certified ISO13485:2003 Medical devices and ISO 9001:2008 for the design and development of microarray test devices.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2012 | Series B | $3.1M | 1/2016 | Venture Round | 1 | $264.9k |
SyndicateRoom SyndicateRoom |
1/2003 | Grant | $16.1M |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|